Targeting the Neddylation Pathway to Suppress the Growth of Prostate Cancer Cells: Therapeutic Implication for the Men's Cancer

The neddylation pathway has been recognized as an attractive anticancer target in several malignancies, and its selective inhibitor, MLN4924, has recently advanced to clinical development. However, the anticancer effect of this compound against prostate cancer has not been well investigated. In this...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Wang, Xiaofang, Li, Lihui, Liang, Yupei, Li, Chunjie, Zhao, Hu, Ye, Dingwei, Sun, Menghong, Jeong, Lak Shin, Feng, Yan, Fu, Shen, Jia, Lijun, Guo, Xiaomao
Format: Artigo
Język:Inglês
Wydane: Hindawi Publishing Corporation 2014
Hasła przedmiotowe:
Research Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4100379/
https://ncbi.nlm.nih.gov/pubmed/25093192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/974309
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy